SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-18-002876
Filing Date
2018-09-27
Accepted
2018-09-27 17:25:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 REGISTRATION STATEMENT xenetic_s3.htm S-3 333852
2 GRAPHIC image_001.jpg GRAPHIC 4500
3 FORM OF SENIOR INDENTURE xenetic_s3-ex0404.htm EX-4.4 462601
4 FORM OF SUBORDINATED INDENTURE xenetic_s3-ex0405.htm EX-4.5 498355
5 OPINION xenetic_s3-ex0501.htm EX-5.1 24534
6 CONSENT xenetic_s3-ex2301.htm EX-23.1 2117
  Complete submission text file 0001683168-18-002876.txt   1328955
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227572 | Film No.: 181091876
SIC: 2834 Pharmaceutical Preparations